New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts-Reference-Cited by-同舟云学术

New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts

Published:2012-10 Issue:7 Volume:39 Page:962-969
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Persson Morten,Rasmussen Palle,Madsen Jacob,Ploug Michael,Kjaer Andreas

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference37 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

3. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases;Glazer;Arch Surg,2010

4. Rational targeting of the urokinase receptor (uPAR): development of inhibitors and non-invasive imaging probes;Kriegbaum;Curr Drug Targets,2010

5. The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer;Mazar;Anticancer Drugs,2001

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic review;Expert Review of Anticancer Therapy;2024-03-11

2. uPAR (PLAUR) Marks Two Intra-Tumoral Subtypes of Glioblastoma: Insights from Single-Cell RNA Sequencing;International Journal of Molecular Sciences;2024-02-07

3. Carrier systems of radiopharmaceuticals and the application in cancer therapy;Cell Death Discovery;2024-01-09

4. Diagnostic Value of Preoperative uPAR-PET/CT in Regional Lymph Node Staging of Oral and Oropharyngeal Squamous Cell Carcinoma: A Prospective Phase II Trial;Diagnostics;2023-10-25

5. Targeted imaging of uPAR expression in vivo with cyclic AE105 variants;Scientific Reports;2023-10-11